Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin

Nature Genetics
D R ScolesS M Pulst

Abstract

NF2 is the most commonly mutated gene in benign tumours of the human nervous system. The NF2 protein, called schwannomin or merlin, is absent in virtually all schwannomas, and many meningiomas and ependymomas. Using the yeast two-hybrid system, we identified betaII-spectrin (also known as fodrin) as a schwannomin-binding protein. Interaction occurred between the carboxy-terminal domain of schwannomin isoform 2 and the ankyrin-binding region of betaII-spectrin. Isoform 1 of schwannomin, in contrast, interacted weakly with betaII-spectrin, presumably because of its strong self-interaction. Thus, alternative splicing of NF2 may regulate betaII-spectrin binding. Schwannomin co-immunoprecipitated with betaII-spectrin at physiological concentrations. The two proteins interacted in vitro and co-localized in several target tissues and in STS26T cells. Three naturally occurring NF2 missense mutations showed reduced, but not absent, betaII-spectrin binding, suggesting an explanation for the milder phenotypes seen in patients with missense mutations. STS26T cells treated with NF2 antisense oligonucleotides showed alterations of the actin cytoskeleton. Schwannomin itself lacks the actin binding sites found in ezrin, radixin and moesin, sug...Continue Reading

References

Jan 1, 1992·Cell Motility and the Cytoskeleton·T VybiralH F Epstein
Oct 1, 1991·The Journal of Cell Biology·S P KennedyJ S Morrow
May 1, 1991·The Journal of Clinical Investigation·V Bennett, S Lambert
Feb 1, 1995·Genes, Chromosomes & Cancer·P MérelJ M Sterkers
Jun 1, 1995·Journal of Medical Genetics·D G EvansT Strachan
Jan 26, 1996·Biochemical and Biophysical Research Communications·J SandersonG Duncan
May 1, 1996·Neurosurgery·V F MautnerS M Pulst
Apr 1, 1997·Journal of Neuropathology and Experimental Neurology·D P HuynhS M Pulst
May 27, 1997·Neuroreport·J O ClaudioG A Rouleau

❮ Previous
Next ❯

Citations

Dec 7, 2000·Journal of Neuroscience Research·M A den BakkerE C Zwarthoff
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Aubri L CharboneauIrene F Newsham
Dec 14, 2011·Acta Neuropathologica·Steven L Carroll
Apr 24, 1999·Biochimica Et Biophysica Acta·J F GusellaL B Jacoby
Oct 31, 2001·Trends in Cell Biology·L S Sherman, D H Gutmann
Aug 7, 2003·Neurobiology of Disease·Victoria A RobbDavid H Gutmann
Mar 4, 2000·Current Opinion in Hematology·P Gascard, N Mohandas
Oct 14, 2000·Annual Review of Cell and Developmental Biology·A BretscherD Reczek
Dec 6, 2005·BMC Evolutionary Biology·Kseniya GolovninaLong-Sheng Chang
Mar 7, 2014·PloS One·Heather S GavilanRichard G Fehon
Jan 10, 2002·Biochemical and Biophysical Research Communications·Daniel R ScolesStefan-M Pulst
Dec 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·Rong RongKeqiang Ye
Jan 16, 2009·Experimental Biology and Medicine·Pil-Soo SeoAthar H Chishti
Sep 19, 2000·Journal of Neurogenetics·D J LimD E Weinstein
Apr 20, 2007·Trends in Cell Biology·Tomoyo OkadaFilippo G Giancotti
Nov 7, 2006·Neuropathology and Applied Neurobiology·C O HanemannT Utermark
Jun 11, 2004·American Journal of Human Genetics·Michael E BaserD Gareth R Evans
Jul 12, 2014·Acta Neuropathologica Communications·Alexander SchulzHelen Morrison
Aug 3, 2002·Nature Reviews. Molecular Cell Biology·Anthony BretscherRichard G Fehon
Sep 11, 2014·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Namal AbeysundaraSarah C Hughes
Nov 2, 1999·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·M A den BakkerT H van der Kwast
Oct 21, 2003·Genes, Chromosomes & Cancer·Guang-Hui XiaoJoseph R Testa
Mar 3, 2004·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Y ChenC E Krull
Jan 2, 2001·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Y KimuraM Nakao
Jul 4, 2001·The Journal of Biological Chemistry·M JannatipourG A Rouleau
May 21, 2004·Nature Reviews. Neuroscience·Vijaya Ramesh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.